Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.

Benzer Materyaller

• NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line
  Yazar:: Saunders, M P, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).
  Yazar:: Patterson, A. V., ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Differentially regulated NADPH:cytochrome P450 oxidoreductases in parsley
  Yazar:: Koopmann, Edda, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?
  Yazar:: Chinje, E C, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
  Yazar:: Guengerich, F Peter, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)